Healionics Analysis: $17M Raised
What is Healionics?
Safer bloodstream access solutions for dialysis
Location
Seattle, United States
Employees
1-10
Founded
2007
Product Features & Capabilities
- STARgraft vascular graft
- STAR® biomaterial scaffold
Other Considerations
Received FDA Breakthrough Device designation for STARgraft; Collaborates with University of Washington and Northwest Kidney Centers; Focused on improving health outcomes for kidney failure patients
